Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15708298 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Condition: Schizophrenia
Intervention: Dietary Supplement: Sarcosine

Indicates status has not been verified in more than two years